cemiplimab,nivolumab,ipilimumab
regeneron,ono Pharmaceuticals,bms
['empowercervical1', 'checkmate358']
results of two studies presented at #esmo2022 by vhio s show the promise of immunotherapy in advanced cervical cancer #empowercervical1 #checkmate358 
Leading translational research to accelerate & advance personalized and targeted therapies against cancer. 
@iCERCA centre